cAMP-dependent phosphorylation system after short and long-term administration of moclobemide

Journal of Psychiatric Research

Volumn 32, Issue 2, 1998, Pages 111-115

  Mori, S ^b   Zanardi, R ^b   Popoli, M ^b   Garbini, S ^b   Brunello, N ^b   Smeraldi, E ^b   Racagni, G ^a   Perez, J ^b  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; INTRAARTICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BENZAMIDES; CEREBRAL CORTEX; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; MALE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYCLIC AMP;

EID: 0032029189     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00003-X     Document Type: Article

References (20)

1. Angst J, Stabl M. Efficacy of moclobemide in different patient groups a meta-analysis of studies. Psychopharmacology 1992;106:109-13.
2. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976;72:248-54.
3. Burkard WP, Bonetti EP, Da Prada M, Martin JR, Polc P, Schaffner R, Scherschlicht R, Hefti F, Muller RKM, Wyss PC, Haefely W. Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamino oxidase type A. Journal of Pharmacology and Experimental Therapeutics 1989;248:391-99.
4. Colzi A, D'Agostini F, Cesura AM, Borroni E, Da Prada M. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo. Journal of Pharmacology and Experimental Therapeutics 1993;265:103-11.
5. Da Prada M, Kettler R, Keller HH, Burkhard WP, Muggli-Maniglio D, Haefely W. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamino oxidase type A. Journal of Pharmacology and Experimental Therapeutics 1989;248:400-14.
6. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Archives of General Psychiatry 1997;54:597-606.
7. Guitart X, Nestler EJ. Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex. Journal of Neurochemistry 1992;59:1164-67.
8. Haefely W, Burkard WP, Cesura AM, Kettler R, Lorez HP, Martin JR, Richards JG, Scherschlict R, Da Prada M. Biochemistry and pharmacology of moclobemide, a prototype RIMA Psychopharmacology 1992;82(suppl.):6-14.
9. Hyman SE, Nestler EJ. Initiation and adaptation: a paradigm for understanding psychotropic drug action. American Journal of Psychiatry 1996;153:151-62.
10. Mochly-Rosen D. Localization of protein kinase by anchoring proteins: a theme in signal transduction. Science 1995;268:247-51.
11. Nestler EJ, Terwilliger RZ, Duman RS. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP dependent protein kinase in rat frontal cortex. Journal of Neurochemistry 1989;53:1644-47.
12. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element-binding protein (CREB) in rat hippocampus. Journal of Neuroscience 1996;16:2365-72.
13. Perez J, Tinelli D, Brunello N, Racagni G. cAMP dependent phosphorylation of soluble and crude mictrotubule fraction of rat cerebral cortex after prolonged desmethylimipramine treatment. European Journal of Pharmacology 1989;172:305-16.
14. Perez J, Tinelli D, Bianchi E, Brunello N, Racagni G. cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology 1991;4:57-64.
15. Perez J, Tinelli D, Cagnoli C, Pecin P, Brunello N, Racagni G. Evidence for the existence of cAMP-dependent protein kinase phosphorylation system associated with specific phosphoproteins in stable microtubules from rat cerebral cortex. Brain Research 1993;602:77-83.
16. Perez J, Mori S, Caivano M, Popoli M, Zanardi R, Smeraldi E, Racagni G. Effects of fluvoxamine on the protein phosphorylation system associated with rat neuronal microtubules. European Neuropsychopharmacology 1995;5(Suppl.):65-9.
17. Racagni G, Brunello N, Tinelli D, Perez J. New biochemical hypotheses on the mechanism of action of antidepressant drugs: cAMP-dependent phosphorylation system. Pharmacopsychiatry 1992;25:51-5.
18. Scott JD. Cyclic nucleotide dependent protein kinase. Pharmacology and Therapeutics 1991;50:123-45.
19. Walaas S, Greengard P. Protein phosphorylation and neuronal function. Pharmacological Reviews 1991;43:299-334.
20. Walter U, Kanof P, Schulman H, Greengard P. Adenosine 3′ : 5′ monophosphate receptor proteins in mammalian brain. The Journal of Biological Chemistry 1978;253:6275-280.